arginine has been researched along with Benign Cerebellar Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bishop, E; Dandapani, M; Dimitrova, M; Estevez-Cebrero, M; Froggatt, A; Grundy, RG; Mussai, F; Paine, S; Storer, LCD | 1 |
Ginsberg, JP; Ham, JN; Hendell, CD; Moshang, T | 1 |
Abayomi, OK; Sadeghi-Nejad, A | 1 |
Li, S; Liu, Y; Sun, P; Ying, H | 1 |
Burger, PC; Green, SB; Mahaley, MS; Mealey, J; Ransohoff, J; Robertson, JT; Selker, RG; Shapiro, WR; Strike, TA; VanGilder, JC | 1 |
1 trial(s) available for arginine and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cerebellar Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Hydroxyurea; Postoperative Care; Procarbazine; Random Allocation; Teniposide | 1989 |
4 other study(ies) available for arginine and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion.
Topics: Adult; Arginase; Arginine; Argininosuccinate Lyase; Brain Neoplasms; Cerebellar Neoplasms; Child; Ependymoma; Glioma; Humans; Medulloblastoma; Ornithine Carbamoyltransferase | 2022 |
Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Topics: Adolescent; Adult; Age of Onset; Arginine; Cerebellar Neoplasms; Cranial Irradiation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemic Agents; Hypopituitarism; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Medulloblastoma; Spine; Stimulation, Chemical | 2005 |
The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma.
Topics: Adolescent; Adult; Arginine; Body Height; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Endocrine System Diseases; Female; Follow-Up Studies; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Male; Medulloblastoma; Radiotherapy | 1986 |
Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Bucladesine; Bystander Effect; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Connexin 43; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Gap Junctions; Gossypol; Humans; Medulloblastoma; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction; Simplexvirus; Temozolomide; Teniposide; Thymidine Kinase | 2012 |